Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Apr 19, 2021 2:25 PM EDT Latest News April 15, 2021 Gilead Sciences to Release First Quarter 2021 Financial Results on Thursday, April 29, 2021 April 13, 2021 U.S. FDA Grants Accelerated Approval to Trodelvy® for the Treatment of Metastatic Urothelial Cancer April 7, 2021 FDA Approves Trodelvy®, the First Treatment for Metastatic Triple-Negative Breast Cancer Shown to Improve Progression-Free Survival and Overall Survival View All Events May 12, 2021 at 7:00 AM EDT Annual Shareholder Meeting Apr 29, 2021 at 4:30 PM EDT First Quarter 2021 Gilead Sciences Earnings Conference Call Mar 15, 2021 Gilead and Merck Collaboration Press Release 206.2 KB Frequently Asked Questions 678.4 KB View All
